YBX3 and colorectal carcinoma: The downregulation of dbpA is a pivotal method to inhibit cell proliferation and induce cell apoptosis as well as cell cycle arrest in cancer cells because it can not only restrict the growth of tumor but also improve the drug sensitivity of CRC cells in vivo (Tong et al., 2020).